Miglustat Gen.Orph Den europeiske union - norsk - EMA (European Medicines Agency)

miglustat gen.orph

gen.orph - miglustat - gaucher sykdom - andre alimentary tract and metabolism products, - miglustat gen. orph er indisert for oral behandling av voksne pasienter med mild til moderat type 1 gaucher sykdom. miglustat gen. orph kan bare bli brukt i behandlingen av pasienter som enzyme replacement therapy er uegnet. miglustat gen. orph er angitt for behandling av progressive nevrologiske manifestasjoner hos voksne pasienter og paediatric pasienter med niemann-pick-type c-sykdom.

Vinorelbin Ebewe 10 mg/ ml Norge - norsk - Statens legemiddelverk

vinorelbin ebewe 10 mg/ ml

ebewe pharma ges.m.b.h nfg. kg - vinorelbintartrat - konsentrat til infusjonsvæske, oppløsning - 10 mg/ ml

Arti-Cell Forte Den europeiske union - norsk - EMA (European Medicines Agency)

arti-cell forte

boehringer ingelheim vetmedica gmbh - chondrogenic indusert equine allogen perifert blod-avledet mesenchymal stem cells - andre legemidler for forstyrrelser i muskel-skjelettsystemet - hester - reduksjon av mild til moderat tilbakevendende halting forbundet med ikke-septisk leddbetennelse i hester.

Dacarbazine Lipomed 500 mg Norge - norsk - Statens legemiddelverk

dacarbazine lipomed 500 mg

lipomed gmbh - dakarbazin - pulver til infusjonsvæske, oppløsning - 500 mg

Dacarbazine Lipomed 1000 mg Norge - norsk - Statens legemiddelverk

dacarbazine lipomed 1000 mg

lipomed gmbh - dakarbazin - pulver til infusjonsvæske, oppløsning - 1000 mg

Mirataz Den europeiske union - norsk - EMA (European Medicines Agency)

mirataz

dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - katter - for kroppsvekt få i katter opplever dårlig appetitt og vekttap som følge av kroniske medisinske tilstander.

Isoprenaline hydrochloride Macure 0.2 mg/ ml Norge - norsk - Statens legemiddelverk

isoprenaline hydrochloride macure 0.2 mg/ ml

macure pharma aps - isoprenalinhydroklorid - konsentrat til infusjonsvæske, oppløsning - 0.2 mg/ ml

Daxocox Den europeiske union - norsk - EMA (European Medicines Agency)

daxocox

ecuphar nv - enflicoxib - antiinflammatoriske og antirheumatiske produkter - hunder - for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.

CircoMax Myco Den europeiske union - norsk - EMA (European Medicines Agency)

circomax myco

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologicals for suidae - griser (for fetende) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Suiseng Diff/A Den europeiske union - norsk - EMA (European Medicines Agency)

suiseng diff/a

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - griser - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.